Parallel Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.93K | Buy |
302
+244
| +421% | +$5.6K | ﹤0.01% | 2595 |
|
2025
Q1 | $1.68K | Buy |
58
+47
| +427% | +$1.36K | ﹤0.01% | 3013 |
|
2024
Q4 | $408 | Hold |
11
| – | – | ﹤0.01% | 3236 |
|
2024
Q3 | $534 | Hold |
11
| – | – | ﹤0.01% | 3156 |
|
2024
Q2 | $440 | Sell |
11
-9
| -45% | -$360 | ﹤0.01% | 3096 |
|
2024
Q1 | $878 | Sell |
20
-75
| -79% | -$3.29K | ﹤0.01% | 2959 |
|
2023
Q4 | $5.88K | Hold |
95
| – | – | ﹤0.01% | 2472 |
|
2023
Q3 | $4.37K | Hold |
95
| – | – | ﹤0.01% | 2545 |
|
2023
Q2 | $5.46K | Hold |
95
| – | – | ﹤0.01% | 2399 |
|
2023
Q1 | $3.56K | Buy |
95
+82
| +631% | +$3.08K | ﹤0.01% | 2545 |
|
2022
Q4 | $364 | Hold |
13
| – | – | ﹤0.01% | 3095 |
|
2022
Q3 | $0 | Sell |
13
-6
| -32% | – | ﹤0.01% | 3095 |
|
2022
Q2 | $1K | Buy |
19
+6
| +46% | +$316 | ﹤0.01% | 2672 |
|
2022
Q1 | $0 | Sell |
13
-100
| -88% | – | ﹤0.01% | 2932 |
|
2021
Q4 | $3K | Buy |
113
+4
| +4% | +$106 | ﹤0.01% | 2535 |
|
2021
Q3 | $2K | Buy |
+109
| New | +$2K | ﹤0.01% | 2623 |
|